Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Future Standard, a Japan-based spinout of Tokyo University of Science, obtained ¥165m ($1.5m) of capital from the university’s Innovation Capital unit yesterday to drive progress on an artificial intelligence-equipped video analytics tool designed to promote industry-academia collaboration through insights and the provision of additional industry internships. The capital will help augment its consulting team to support the development and launch of the technology, which has been dubbed Scorer.  It marks the first investment for Tokyo University of Science Innovation Capital, which is expected to have raised $8.3m of funding by the end of this year. Investment firm Kingdom Capital yesterday launched a new US-based business called PercayAI to commercialise augmented intelligence-powered drug discovery software on the back of Washington University in St Louis’s School of Medicine research. PercayAI’s first product, CompBio, can emulate the thought processes of biological science experts, using contextual language processing and artificial intelligence to rapidly identify otherwise imperceptible trends within biological data sets. The technology extends research from the Genome Technology Access Centre (GTAC) at the university’s McDonnel Genome Institute, pioneered by GTAC’s director Richard Head.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?